Correction: Bispecific nanobodies targeting Bet v 1 and ICAM-1 decrease respiratory epithelial penetration of Bet v 1 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Bispecific Nanobodies Targeting Bet v 1 and ICAM-1 Reduce Penetration of Bet v 1 in Respiratory Epithelial Cells

  • By

  • Ines Zettl

  • Isabella Ellinger

  • Mohammed Zghaebi

  • Sarah Jance

  • Vanessa Izewski

  • Anja Drescher

  • Heimo Breiteneder

  • Manuel Röck

  • Martin Tollinger

  • Julia Eckl-Dorna

  • Sergei V. Tillib

  • Sabine Flicker

  • September 11, 2026

Share

Objective:

To correct and update the findings regarding bispecific nanobodies targeting Bet v 1 and ICAM-1 in relation to their effects on respiratory epithelial penetration.

Approach:
  • Correction Details: The article includes a new citation to a 2025 study on airway epithelial barrier penetration by birch Bet v 1 and alder Aln g 1 pollen allergens, which was previously omitted.
  • Reference Update: The numbering sequence for references has been revised to accommodate the new citation.
Key Findings:
  • Bet v 1 actively penetrates monolayers of healthy respiratory epithelial cells.
  • Synthetic nanobody libraries can reproduce an individual's clonal diversity.
Interpretation:

The correction emphasizes the importance of accurate citations and updates in scientific literature.

Limitations:
  • The article does not provide new experimental data or findings beyond the correction.
Conclusion:

The correction enhances the understanding of Bet v 1 interactions with respiratory epithelial cells.

Sources:

Original Source(s)

Related Content